Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2013	Sep. 30, 2012
Cash flows from operating activities
Net earnings	$ 155,652	$ 205,700
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation of plant and equipment	75,526	75,113
Amortization of intangibles	37,677	34,792
Program production cost amortization	34,023	25,950
Deferred income taxes	604	(1,694)
Stock-based compensation	20,599	18,040
Change in operating assets and liabilities:
Increase in accounts receivable	(203,159)	(141,259)
Increase in inventories	(133,738)	(125,472)
Increase in prepaid expenses and other current assets	(20,672)	(196)
Program Production Costs	(31,520)	(41,195)
Increase in accounts payable and accrued liabilities	222,695	72,486
Other, including long-term portion of royalty advances	(110,370)	21,351
Net cash provided by operating activities	47,317	143,616
Cash flows from investing activities
Additions to property, plant and equipment	(78,246)	(74,896)
Investments and acquisitions, net of cash acquired	(109,955)	0
Other	3,121	2,558
Net cash utilized by investing activities	(185,080)	(72,338)
Cash flows from financing activities
Net (repayments of) proceeds from short-term borrowings	(11,235)	83,380
Purchases of common stock	(86,972)	(15,079)
Stock option transactions	74,400	40,661
Excess tax benefits from stock-based compensation	12,772	8,521
Dividends paid	(104,164)	(132,231)
Net cash utilized by financing activities	(115,199)	(14,748)
Effect of exchange rate changes on cash	(8,071)	(1,485)
(Decrease) increase in cash and cash equivalents	(261,033)	55,045
Cash and cash equivalents at beginning of year	849,701	641,688
Cash and cash equivalents at end of period	588,668	696,733
Cash paid during the period for:
Interest	76,700	79,724
Income taxes	$ 50,548	$ 50,446